Glades Pharmaceuticals Announces the Launch of Griseofulvin Antifungal Agent.DULUTH, Ga. -- Glades Pharmaceuticals, LLC (Logical Link Control) See "LANs" under data link protocol. LLC - Logical Link Control , a wholly-owned subsidiary of Stiefel Laboratories, Inc., the world's largest independent pharmaceutical company specializing in dermatology, today announced it has received FDA FDA abbr. Food and Drug Administration FDA, n.pr See Food and Drug Administration. FDA, n.pr the abbreviation for the Food and Drug Administration. approval for Griseofulvin griseofulvin /gris·eo·ful·vin/ (gris?e-o-ful´vin) an antibiotic produced by Penicillium griseofulvum ; used as an antifungal in dermatophytoses. gris·e·o·ful·vin n. Oral Suspension, USP USP - unique sales point 125 mg/5 mL. This product is the first and only AB rated generic version of Grifulvin V(R). Griseofulvin Oral Suspension, USP acts systemically to inhibit the growth of Trichophyton, Microsporum, and Epidermophyton genera of fungi. Major indications for Griseofulvin Oral Suspension, USP are Tinea capitis tinea cap·i·tis n. A fungal infection of the scalp, characterized by patches of apparent baldness, scaling, black dots, and occasionally erythema and pyoderma. (ringworm ringworm or tinea (tĭn`ēə), superficial eruption of the skin caused by a fungus, chiefly Microsporum, Trichophyton, or Epidermophyton. of the scalp), Tinea corporis tinea cor·po·ris n. A fungal infection of the body, characterized by a scaling macular eruption that frequently forms annular lesions on nonhairy parts of the body. (ringworm of the body), Tinea pedis (athlete's foot), Tinea unguium (onychomycosis; ringworm of the nails) and Tinea cruris (ringworm of the thigh). "By offering the first AB rated generic version of the widely prescribed Grifulvin V(R), we will enable healthcare providers and the distribution channel to bring a more cost effective version of this therapy to patients," said Jeffrey S. Thompson, President, Glades Pharmaceuticals. "This is an important addition to our product line." Full prescribing information for Griseofulvin Oral Suspension, USP, as well as for all other Glades Pharmaceuticals prescription products, is available by contacting 1-888-4GLADES or 1-888-445-2337. About Glades Glades Pharmaceuticals, LLC, was formed in 1991 and is a wholly-owned subsidiary of Stiefel Laboratories, Inc., the world's largest independent pharmaceutical company specializing in dermatology with global presence and more than 150 years of heritage and success. Glades, specializes in the sales and marketing of safe and effective high-quality generic, branded-generic, and branded pharmaceutical products. Glades is committed to providing superior service and exceptional quality for patients, pharmacists, and business partners. We invite you to visit our website, http://www.Glades.com. (1) Grifulvin V(R) is a registered trademark of Johnson & Johnson. Glades Pharmaceuticals, LLC is not affiliated with Johnson & Johnson. Federal and State laws govern the substitution of prescription drugs and we encourage you to apply the appropriate substitution for your locale. (C)2005 Glades Pharmaceuticals, LLC. All Rights Reserved. |
|
||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion